Search Results 21-30 of 17102 for nivolumab
About this study. The trial is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma.
Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells. Participation eligibility. Participant ...
A Study To Evaluate The Use Of Nivolumab And Pomalidomide Combination For Relapsed/Refractory Primary Central Nervous System Lymphoma And Primary Vitreoretinal ...
Study Of Nivolumab In Combination With Ipilimumab Versus Nivolumab In Combination With Ipilimumab Placebo In Patients With Recurrent Or Metastatic Squamous ...
The purpose of this study is to determine whether Nivolumab in combination ... Nivolumab by itself in treating unresectable Melanoma or Melanoma that has spread ...
The purpose of this study is to determine whether Nivolumab, in combination with brentuximab vedotin, is safe and effective in patients with certain subtypes of ...
The purpose of this study is to determine how well nivolumab, with or without ipilimumab, works in treating patients with anal canal cancer that has not ...
Giving ipilimumab and nivolumab may lower the chance of recurrent glioblastoma with high number of mutations from growing or spreading compared to usual care ( ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
... nivolumab on overall survival (OS) and to compare the effect of RP2 + nivolumab relative to ipilimumab + nivolumab on progression free survival (PFS).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.